NP方案治疗晚期非小细胞肺癌疗效分析  

Analysis of the Effects of the Treatment of Non-small Cell Lung Cancer with Navelbine Combined Cisplatin

作　　者：姜维美[1] 蒋华[1] 张岩[1] 

机构地区：[1]连云港市第二人民医院肿瘤内科,江苏连云港222023

出　　处：《河南肿瘤学杂志》2002年第2期114-115,共2页Henan Journal of Oncology

摘　　要：目的　观察NP方案治疗晚期非小细胞肺癌的疗效。方法　 17例患者均以NP方案 (NVB 2 5mg/m2 d1,d8;PDD 3 0mg/m2 d1～ 3 )化疗 2～ 3周期。结果　CR 1例 ,PR 7例 ,NC 5例 ,PD 4例 ,总有效率 :47 1% (8/ 17) ,中位生存时间 (MST) 9个月 ,最长生存期 2 7个月。Objective To observe the therapeutic effects of navelbine plus cisplatin for the treatment of non-small Cell lung cancer.Methods 17 cases were treated with navelbine and cisplatin(NVB 25 mg/m 2 d 1,d 8;PDD 30 mg/m 2 d 1～3 ) Results The complete response had one,and partial response had seven.The total effective rate was 47.1%(8/17) MST was 9 months. The longest survival period was 27 months.Conclusion NP regimen is one of the effective ways to treat non-small-cell lung cancer.

关 键 词：晚期 非小细胞肺癌 NP方案 化疗 

分 类 号：R734.2[医药卫生—肿瘤] R730.53[医药卫生—临床医学]